BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 8.75% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 8.32% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 7.94% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 5.94% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 5.37% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.98% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 4.80% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.67% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.49% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.22% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 3.44% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.42% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.21% |
| CMPS | Compass Pathways Plc | Healthcare | Medical Care Facilities | 3.10% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 2.99% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 2.39% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Diagnostics & Research | 2.24% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 2.20% |
| BFLY | Butterfly Network Inc | Healthcare | Medical Devices | 1.73% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.72% |